TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/17/22 21:51 | 5/16/22 | TFFP | Tff Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mattes Glenn R. | TX | DO | P,CEO | P | 76 | 4.78 | 0 | 16 | 59 | 43 | D | ||||||||||||||
9/16/21 13:35 | 9/16/21 | TFFP | Tff Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mattes Glenn R. | TX | DO | P,CEO | P | 71 | 7.10 | 0 | 10 | 59 | 27 | D | ||||||||||||||
10/30/19 20:02 | 10/25/19 | TFFP | Tff Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mattes Glenn R. | TX | DO | P,CEO | P.ad | 100 | 5.00 | 0 | 20 | New | 20 | M | ||||||||||||||
10/29/19 20:27 | 10/25/19 | TFFP | Tff Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Mattes Glenn R. | TX | DO | P,CEO | P.d | 50 | 5.00 | 0 | 10 | New | 10 | D | ||||||||||||||
10/31/13 19:36 | 10/29/13 | ARNI | Arno Therapeutics, Inc | DE | Health | Drug | Pharmaceutical Preparations | Mattes Glenn R. | NJ | DO | P,CEO | P.d | 0 | 0.00 | 0 | 21 | 37 | 77 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |